EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing Liquiritigenin: A Flavonoid-Based Approach for the Prevention and Treatment of Cancer

Anjana Sajeev, Babu Santha Aswani, Mohammed S Alqahtani iD, Mohamed Abbas iD, Gautam Sethi, Ajaikumar B Kunnumakkara

Cancers · 13.07.2025 · 17 (14) · 2328

DOI: 10.3390/cancers17142328 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.07.2025. Verfasst von Anjana Sajeev und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati 781039, Assam, Indi…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ajaikumar B. Kunnumakkara’s Professional Development Fund (PDF), IIT Guwahati.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The integration of natural compounds in cancer research marked a crucial shift in the modern medical landscape, through a growing acknowledgment of their potential as efficient, less toxic, and cost-effective alternatives to contemporary chemotherapeutics. Liquiritigenin (LIQ) is a compound obtained from different plants, the most important being the Glycyrrhiza species, commonly known as licorice.

Methods

This review compiles findings from previously published preclinical studies and experimental research articles focusing on LIQ’s pharmacological effects, with particular attention to its anticancer potential. The relevant literature was identified using established scientific databases and selected based on relevance to cancer biology and LIQ-associated signaling pathways.

Results

LIQ demonstrates anti-oxidant, anti-inflammatory, and anti-proliferative effects. It exerts its potential anticancer activities by inducing apoptosis, preventing cell proliferation, and modulating various signaling pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), phosphoinositide 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK), and so on.

Conclusions

LIQ represents a promising natural agent for cancer therapy, with evidence supporting its multifunctional role in targeting tumor growth and survival mechanisms. By providing a detailed analysis of LIQ, this review aims to highlight its therapeutic efficacy across various cancer types and emphasize its importance as a promising compound in cancer research. In addition, this review seeks to bridge the gap between traditional medicine and modern pharmacology and paves the way for LIQ’s clinical application in cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

cancer therapychemosensitizationliquiritigeninpharmacokineticsphytochemicalsignaling pathways

Autor:innen und Institutionen

  • Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati 781039, Assam, India.
  • Radiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha 61421, Saudi Arabia.
  • BioImaging Unit, Space Research Centre, Michael Atiyah Building, University of Leicester, Leicester LE1 7RH, UK.
  • Electrical Engineering Department, College of Engineering, King Khalid University, Abha 61421, Saudi Arabia.
  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.

ORCID-Profile: Mohammed S Alqahtani, Mohamed Abbas

Förderung

  • Ajaikumar B. Kunnumakkara’s Professional Development Fund (PDF)
  • IIT Guwahati

Zitieren

APA

Sajeev, A., Aswani, B. S., Alqahtani, M. S., Abbas, M., Sethi, G., & Kunnumakkara, A. B. (2025). Harnessing Liquiritigenin: A Flavonoid-Based Approach for the Prevention and Treatment of Cancer. Cancers, 17(14), 2328. https://doi.org/10.3390/cancers17142328

Vancouver

Sajeev A, Aswani BS, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Harnessing Liquiritigenin: A Flavonoid-Based Approach for the Prevention and Treatment of Cancer. Cancers. 2025;17(14):2328. doi:10.3390/cancers17142328

BibTeX
@article{Sajeev2025,
  author = {Sajeev, Anjana and Aswani, Babu Santha and Alqahtani, Mohammed S and Abbas, Mohamed and Sethi, Gautam and Kunnumakkara, Ajaikumar B},
  title = {Harnessing Liquiritigenin: A Flavonoid-Based Approach for the Prevention and Treatment of Cancer},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {14},
  pages = {2328},
  doi = {10.3390/cancers17142328}
}
Kostenlos starten →